Scientists infused autologous T cells transduced with a CD19-directed chimeric antigen receptor lentiviral vector in patients with refractory or relapsed acute lymphoblastic leukemia (ALL). This evidence concerns the gene CD19 and acute lymphoblastic leukemia.